Quick Albuminuria Reduction Key Factor in Finerenone's Efficacy
(MedPage Today) -- Early albuminuria reduction with finerenone (Kerendia) drove protection against chronic kidney disease (CKD) progression in people with type 2 diabetes, according to a post-hoc mediation analysis.
In the pooled analysis using...
Source: MedPage Today Nephrology - Category: Urology & Nephrology Source Type: news
More News: Chronic Kidney Disease | Diabetes | Diabetes Type 2 | Endocrinology | Urology & Nephrology